Point72 Middle East FZE’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,200
Closed -$1.68M 587
2023
Q4
$1.68M Sell
6,200
-11,000
-64% -$2.72M 0.05% 443
2023
Q3
$4.23M Buy
17,200
+12,300
+251% +$3.37M 0.14% 192
2023
Q2
$1.49M Buy
4,900
+1,100
+29% +$306K 0.04% 456
2023
Q1
$1M Buy
3,800
+3,400
+850% +$864K 0.03% 498
2022
Q4
$96K Buy
+400
New +$89.6K ﹤0.01% 1286

Other funds holding HCA

Point72 Middle East FZE's HCA Position: Q4 2023 in Review

Point72 Middle East FZE sold out of HCA Healthcare (HCA) in Q4 2023, closing a stake of 64,685 shares — an estimated $16M sold.

Point72 Middle East FZE first reported a position in HCA in Q4 2022 and held it in 2 quarters. The position peaked at $15.9M in Q3 2023. 1,057 funds tracked by Wall St. Rank hold HCA as of Q4 2023.

  • Point72 Middle East FZE reported no remaining HCA Healthcare position as of Q4 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 64,685 HCA Healthcare shares in Q4 2023, an estimated $16M.
  • Point72 Middle East FZE first reported a position in HCA Healthcare in Q4 2022 and held it in 2 quarters.
  • Point72 Middle East FZE's HCA Healthcare position peaked at $15.9M in Q3 2023.
  • 1,057 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2023.

Based on Point72 Middle East FZE's 13F filing for Q4 2023, filed 14 Feb 2024.